# Yarrow Bioscience Inc (YARW)

> Source: Nexqual · https://nexqual.com/YARW · data as of 2026-10-15 20:00 UTC · cite as "Nexqual, Yarrow Bioscience Inc (YARW), nexqual.com/YARW" · informational, not investment advice.

**Price:** USD 20 (+5.82% on the day) · last close of Oct 15, 2026; US market closed, not a live price. Prev close 18.9 · day 18.85–20.05 · 52w 16.05–46.95 · market cap $186M · NCM

## Key facts
- Analysts: Buy (mean 2.00 on a 1–5 scale) (3 analysts), mean target USD 57 (range 56–58).
- Total return with dividends: 1Y +96.3% vs S&P 500 +18.1%; 5Y -96.8% vs S&P 500 +85.1%.

## Analysts
Consensus Buy (mean 2.00 on a 1–5 scale), 3 analysts; mean target USD 57 (low 56, high 58).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-08-03 | BTIG | Initiated | Buy | $58 |
| 2026-07-28 | TD Cowen | Initiated | Buy |  |

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-16) | 5Y (from 2021-10-11) |
|---|---|---|
| Total return | +96.3% | -96.8% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | +96.8% | -49.6% |
| Volatility (annualized) | 69.1% | 112.0% |
| Max drawdown | -56.7% (Aug 2026→Oct 2026) | -98.9% (Dec 2021→Sep 2025) |

## Peers (Biotechnology)
RYTM (Rhythm Pharmaceuticals, Inc.) USD 87.97 +1.57% · BLTE (Belite Bio, Inc) USD 152.62 +0.49% · IOVA (Iovance Biotherapeutics, Inc.) USD 14.72 +1.52% · PRAX (Praxis Precision Medicines, Inc) USD 248.24 +2.01% · IONS (Ionis Pharmaceuticals, Inc.) USD 44.12 +4.11% · SYRE (Spyre Therapeutics, Inc.) USD 80.1 -0.44%

## More
Full page: https://nexqual.com/YARW · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt